
RGPD LFPDPPP, ISO 27001 Mexico City, GxP validation. How to align your European parent company’s standards with the Mexican reality without duplicating efforts.
Managing the technology compliance of a Mexican subsidiary from Europe is not simply a matter of translating internal policies into another language. It involves navigating two regulatory frameworks with their own logic, different deadlines, and independent oversight authorities. This article provides a structured guide for DPO IT VPs or DPO who need to ensure compliance in both jurisdictions without duplicating efforts.
The European General Data Protection Regulation (RGPD) and Mexico’s Federal Law on the Protection of Personal Data Held by Private Parties (LFPDPPP) share the same underlying philosophy: personal data belongs to the individual, and its processing must be legitimate, transparent, and limited to the purpose for which it is collected.
However, the similarities end there. The RGPD a regulation that is directly and immediately applicable, with penalties proportional to global revenue (up to 4% of worldwide revenue). The LFPDPPP, in effect since 2010, delegates oversight to INAI National Institute for Transparency) and provides for lower financial penalties, although noncompliance still exposes the company to administrative penalties and significant reputational damage.
A key point: the LFPDPPP generally require a Data Protection Officer. The RGPD , when processing is on a large scale or involves special categories of data. This asymmetry creates organizational tension when the European parent company exports its governance model.
The ISO 27001 standard ISO 27001 applicable worldwide, but its practical implementation varies by market. In Europe, certification bodies accredited by ENAC (Spain), COFRAC (France), or SAS (Switzerland) have a proven track record, and the market is accustomed to rigorous audits and annual surveillance cycles.
In Mexico, ISO 27001 certification ISO 27001 on the rise, but the ecosystem of accredited bodies is smaller. The Mexican accreditation body is EMA Entidad Mexicana de Acreditación). For a subsidiary whose parent company is already certified in Europe, the most efficient approach is to extend the scope of the existing certificate, incorporating the Mexican sites under the same ISMS, with combined audits and local adaptations of the Information Security Management System.
Specific areas of focus for Mexico City include: managing local cloud and telecommunications providers; controlling physical access in offices with high staff turnover; and managing risks associated with electrical infrastructure and business continuity in the event of seismic contingencies.
Pharmaceutical companies with subsidiaries in Mexico must comply with Good Manufacturing Practices (GMP) overseen by COFEPRIS Federal Commission for Protection against Health Risks), the functional equivalent of the EMA or the FDA. The validation of IT systems in GxP environments GxP LIMS, ERP , and quality management systems—follows the GAMP 5 guidelines, which are recognized in both Europe and Mexico.
However, COFEPRIS its own inspections and may require documentation in Spanish, with local validation evidence. It is not sufficient to submit the European dossier: there must be evidence that IQ/OQ/PQ protocols have been carried out IQ/OQ/PQ the Mexican setting, with local traceability and a signature authorized by the site’s quality assurance manager.
A Mexican subsidiary that complies simultaneously with the RGPD, the LFPDPPP local industry requirements not only avoids penalties—it also projects an image of reliability to customers, partners, and regulators in both markets. The key is not to build two parallel systems, but to design an integrated compliance architecture from the outset.
With 30 years of experience supporting European subsidiaries in Mexico, Keptos developed a cross-border audit methodology that identifies actual gaps, prioritizes risks, and proposes an actionable remediation plan. Request your free IT compliance audit and receive a clear assessment of your regulatory status in both jurisdictions in less than two weeks.
30 minutes with one of our directors. No sales pitch—straight to the point.